HARTE-HANKS

 HHSのチャート


 HHSの企業情報

symbol HHS
会社名 Harte Hanks Inc (HARTE-HANKS)
分野(sector)   
産業(industry)   
業種 広告_マ―ケティング   サ―ビス(Services)
概要 ハート・ハンクス(Harte-Hanks Inc.)は地元・地方・国家・国際の消費者及び企業間の販売業者に、直販サービス及びショッパー広告業務を提供する世界的なダイレクトマーケティング会社。同社は国内外で事業を行う直接販売事業部門及びカリフォルニア州フロリダ州の地元・地方市場で事業を展開するショッパー事業部門により構成される。Harte-Hanks Shoppersはショッパー出版物を所有・経営・提供する会社(発行部数と収入に基づく)。平成23年12月期決算期において、直接販売事業の収益とショッパー事業の収益はそれぞれ同社の総収益の72%と28%を占めた。  ハ―ト・ハンクスは、米国のマ―ケティング会社。ウェブサイトの開発、デザインなどの代理店・デジタルサ―ビス、デ―タベ―スマ―ケティングソリュ―ションのほか、デ―タクレンジング・名寄せツ―ルの「トリリアム」ソフトウェア、デジタル印刷や発送業務などのダイレクトメ―ルサ―ビス、さらに多言語対応のカスタマ―サ―ビスを提供する。  Harte-Hanks, Inc. engages in the provision of marketing solutions. It specializes in consulting, data analytics, creative services, digital and social media, marketing strategy, marketing technology, and other related services. It supports a range of customers in the field of technology, travel and leisure, entertainment, pharmaceuticals, automotive, finance, and retail. The company was founded in 1923 and is headquartered in San Antonio, TX.
本社所在地 9601 McAllister Freeway Suite 610 San Antonio TX 78216 USA
代表者氏名 Alfred V. Tobia
代表者役職名 Chairman of the Board
電話番号 +1 210-829-9000
設立年月日 25842
市場名 NYSE(ニューヨーク証券取引所)
ipoyear
従業員数 5652人
url www.HarteHanks.com
nasdaq_url
adr_tso
EBITDA (百万ドル) -13.69300
終値(lastsale)
時価総額(marketcap)
時価総額 (百万ドル) 23.05936
売上高 (百万ドル) 284.62800
企業価値(EV) (百万ドル) 26.10036
当期純利益 (百万ドル) 14.89100
決算概要 BRIEF: For the fiscal year ended 31 December 2018 Harte Hanks Inc revenues decreased 26% to $284.6M. Net income applicable to common stockholders excluding extraordinary items totaled $14.9M vs. loss of $45.3M. Revenues reflect United States segment decrease of 26% to $243.3M Other Countries segment decrease of 22% to $41.3M. Net Income reflects Gain on sale increase from $0K to $31M (income) Advertising Expenses decrease of 15% to $34.2M (expense).

 HHSのテクニカル分析


 HHSのニュース

   'Fauci is not 100% right': Top HHS official pushes back on infectious disease expert's recommendations  2020/07/12 17:50:34 Washington Examiner
Adm. Brett Giroir pushed back on some of the public health recommendations made by his colleague on the White House Coronavirus Task Force, Dr. Anthony Fauci.
   Top HHS official says 'simple' behavior changes would curb pandemic  2020/07/12 14:07:00 NBC News
Steps like closing bars and wearing masks could have the same impact as widespread economic shutdowns, Admiral Brett Giroir said Sunday.
   Trump sidelines public health advisers in growing rift over coronavirus response  2020/07/09 21:33:00 The Washington Post
Email from HHS adviser accusing CDC of ‘undermining President’ offers window into pressure on nation’s public health agency.
   Trump's hydroxychloroquine obsession cost taxpayers at least $88 million  2020/07/08 15:48:29 Business Insider
President Trump repeatedly hyped an obscure antimalarial drug, hydroxychloroquine, as a potential miracle cure for COVID-19. But there was almost no solid scientific evidence to back that claim, and researchers quickly established that it had no effect on the disease. Despite its unlikely profile as a cure, hydroxychloroquine has received more federal research funding than any other single potential treatment, an Insider investigation has found. Taxpayers have devoted at least $88 million — and likely much more — on research and prescriptions for the drug. "It's been a disaster," Arthur Caplan, the founder of New York University School of Medicine's division of medical ethics, said. "There's too much money … chasing around that drug based on very weak evidence in the literature and a presidential endorsement." Visit Business Insider's homepage for more stories . Most Americans had never heard of hydroxychloroquine — the obscure antimalarial drug discovered in 1945 — until March 19. That's when President Donald Trump, speaking at a Coronavirus Task Force press conference in the White House briefing room with the blustering confidence of an old-time snake-oil salesman, first touted it as a likely miracle cure to defeat COVID-19.
   Department of Health and Human Services to open 'surge' COVID-19 testing in Florida, Texas, Louisiana  2020/07/07 19:08:06 Channel NewsAsia
The U.S. Department of Health and Human Services (HHS) said on Tuesday there would be temporary free COVID-19 testing in three cities in Florida, Louisiana and Texas as the U.S. states tackle surging cases and hospitalizations.
   'Fauci is not 100% right': Top HHS official pushes back on infectious disease expert's recommendations  2020/07/12 17:50:34 Washington Examiner
Adm. Brett Giroir pushed back on some of the public health recommendations made by his colleague on the White House Coronavirus Task Force, Dr. Anthony Fauci.
   Top HHS official says 'simple' behavior changes would curb pandemic  2020/07/12 14:07:00 NBC News
Steps like closing bars and wearing masks could have the same impact as widespread economic shutdowns, Admiral Brett Giroir said Sunday.
   Trump sidelines public health advisers in growing rift over coronavirus response  2020/07/09 21:33:00 The Washington Post
Email from HHS adviser accusing CDC of ‘undermining President’ offers window into pressure on nation’s public health agency.
   Trump's hydroxychloroquine obsession cost taxpayers at least $88 million  2020/07/08 15:48:29 Business Insider
President Trump repeatedly hyped an obscure antimalarial drug, hydroxychloroquine, as a potential miracle cure for COVID-19. But there was almost no solid scientific evidence to back that claim, and researchers quickly established that it had no effect on the disease. Despite its unlikely profile as a cure, hydroxychloroquine has received more federal research funding than any other single potential treatment, an Insider investigation has found. Taxpayers have devoted at least $88 million — and likely much more — on research and prescriptions for the drug. "It's been a disaster," Arthur Caplan, the founder of New York University School of Medicine's division of medical ethics, said. "There's too much money … chasing around that drug based on very weak evidence in the literature and a presidential endorsement." Visit Business Insider's homepage for more stories . Most Americans had never heard of hydroxychloroquine — the obscure antimalarial drug discovered in 1945 — until March 19. That's when President Donald Trump, speaking at a Coronavirus Task Force press conference in the White House briefing room with the blustering confidence of an old-time snake-oil salesman, first touted it as a likely miracle cure to defeat COVID-19.
   Department of Health and Human Services to open 'surge' COVID-19 testing in Florida, Texas, Louisiana  2020/07/07 19:08:06 Channel NewsAsia
The U.S. Department of Health and Human Services (HHS) said on Tuesday there would be temporary free COVID-19 testing in three cities in Florida, Louisiana and Texas as the U.S. states tackle surging cases and hospitalizations.
   'Fauci is not 100% right': Top HHS official pushes back on infectious disease expert's recommendations  2020/07/12 17:50:34 Washington Examiner
Adm. Brett Giroir pushed back on some of the public health recommendations made by his colleague on the White House Coronavirus Task Force, Dr. Anthony Fauci.
   Top HHS official says 'simple' behavior changes would curb pandemic  2020/07/12 14:07:00 NBC News
Steps like closing bars and wearing masks could have the same impact as widespread economic shutdowns, Admiral Brett Giroir said Sunday.
   Trump sidelines public health advisers in growing rift over coronavirus response  2020/07/09 21:33:00 The Washington Post
Email from HHS adviser accusing CDC of ‘undermining President’ offers window into pressure on nation’s public health agency.
   Trump's hydroxychloroquine obsession cost taxpayers at least $88 million  2020/07/08 15:48:29 Business Insider
President Trump repeatedly hyped an obscure antimalarial drug, hydroxychloroquine, as a potential miracle cure for COVID-19. But there was almost no solid scientific evidence to back that claim, and researchers quickly established that it had no effect on the disease. Despite its unlikely profile as a cure, hydroxychloroquine has received more federal research funding than any other single potential treatment, an Insider investigation has found. Taxpayers have devoted at least $88 million — and likely much more — on research and prescriptions for the drug. "It's been a disaster," Arthur Caplan, the founder of New York University School of Medicine's division of medical ethics, said. "There's too much money … chasing around that drug based on very weak evidence in the literature and a presidential endorsement." Visit Business Insider's homepage for more stories . Most Americans had never heard of hydroxychloroquine — the obscure antimalarial drug discovered in 1945 — until March 19. That's when President Donald Trump, speaking at a Coronavirus Task Force press conference in the White House briefing room with the blustering confidence of an old-time snake-oil salesman, first touted it as a likely miracle cure to defeat COVID-19.
   Department of Health and Human Services to open 'surge' COVID-19 testing in Florida, Texas, Louisiana  2020/07/07 19:08:06 Channel NewsAsia
The U.S. Department of Health and Human Services (HHS) said on Tuesday there would be temporary free COVID-19 testing in three cities in Florida, Louisiana and Texas as the U.S. states tackle surging cases and hospitalizations.

 関連キーワード  (広告_マ―ケティング 米国株 HARTE-HANKS HHS )

「広告」は、消費者に関心を持たせ、購入させるために、有料の媒体を用いて商品の宣伝をすること。また、そのための文書類や画像、映像、構造物など。ダイレクトメール、チラシ、折り込みなどの広告もある。 従来はテレビ、ラジオ、新聞、雑誌が広告の4大マス(大衆)媒体とされてきたが、近年ではインターネット広告が急成長をみせている。全世界に発信できるうえ、動画や音声を送ることが可能で、双方向で利用者の意見や嗜好を把握できるという利点がある。また、スマートフォンの普及加速もこれに拍車をかけており、インターネット広告市場は今後も飛躍的な成長をみせそうだ。

 twitter  (公式ツイッターやCEOツイッターなど)